Health Technology: Vaccines, Diagnostics, and Medical Devices

This note focuses on the diagnostics and medical devices ecosystem in India, complementing the broader vaccine note. Diagnostics: RT-PCR, RAT, ELISA, CBNAAT, NGS, point-of-care. Medical devices: PLI scheme, MDC 2017, CDSCO regulation, NPPA price control, import dependence (80%). Digital health: ABDM, e-Sanjeevani, UHI, telemedicine.[TOPIC CLASSIFICATION]

• Topic type: Science & Technology - Health Tech
• PYQ frequency: Medium
• Exam stage: Prelims + Mains
• Primary GS paper: GS 3

[EXAMINER REASONING]

1. Trap: Confusing CDSCO (regulator) with NPPA (price control). CDSCO approves drugs/devices; NPPA caps prices (stents, knee implants). Many aspirants mix their mandates.
2. Most confused: Medical device classification: Class A (low risk, self-certification) to Class D (high risk, full clinical trials). MDC 2017 aligned with GHTF/IMDRF. Many aspirants don't know the risk-based classification.
3. Key anchor: PLI Scheme (Rs 3,420 cr) for medical device manufacturing to reduce 80% import dependence. MDC 2017 (CDSCO) for regulation. NPPA for price caps (coronary stents, knee implants). ABDM for digital health infrastructure.
4. Current affairs hook: PLI Scheme 2.0 for medical devices. ICD-11 adoption (2022). India as 'pharmacy of the world' for vaccines. Diagnostics PLI for kits. NPPA price caps on stents (Rs 30,180) and knee implants.
5. Mains hinge: Evaluate: Can India achieve self-reliance in medical devices? The 80% import dependence, PLI incentives, regulatory capacity (CDSCO), and the balance between innovation and affordability is the Mains frame.

---

Core Concept

Diagnostics ecosystem: RT-PCR (molecular, gold standard), Rapid Antigen Test (antigen, 15-30 min), ELISA (antibody/antigen), CBNAAT (TB, GeneXpert), NGS (genomic surveillance), Point-of-care (POCT). ICMR validates kits. COVID-19 scaled RT-PCR from 1 lab to 3000+ labs.

Medical Devices: PLI Scheme (Rs 3,420 cr, 2021) for 4 categories: cancer/radiotherapy, anesthetics/cardiology, imaging, implants. Target: reduce 80% import dependence. MDC 2017 (Medical Device Rules, CDSCO) classifies by risk: Class A (low, thermometer), B (low-moderate, syringe), C (moderate-high, dialysis), D (high, implants, stents). Clinical trial requirements increase with class.

Regulation: CDSCO (Central Drugs Standard Control Organization) under MoHFW is the national regulator. NPPA (National Pharmaceutical Pricing Authority) caps prices: coronary stents (Rs 30,180 bare metal, Rs 30,180 drug-eluting), knee implants. Essential Medical Devices List.

Digital Health: ABDM (Ayushman Bharat Digital Mission): ABHA ID (50+ cr), UHI (Unified Health Interface), e-Sanjeevani (telemedicine, 20+ cr consultations), HFR, HPR. NDHM/ABDM interoperability via UHI. Telemedicine Practice Guidelines (2020).